David A. Piacquad joined Amgen in 2010 and was named senior vice president, Business Development, in March 2014, and Senior Vice President in September 2021. Prior to these roles, Piacquad served as vice president, Strategy & Corporate Development, responsible for mergers and acquisitions, inbound and outbound Licensing, Amgen Ventures and Corporate Alliance Management.
Prior to Amgen, Piacquad was senior vice president, Business Development & Licensing at Schering-Plough Corporation. Before joining Schering-Plough, Piacquad spent more than 20 years at Johnson & Johnson, where he held a series of leadership roles in finance and business development.
Piacquad holds a BA degree from Colgate University and an MBA from the Wharton School.